Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Dec 27;25(1):440.
doi: 10.1186/s12875-024-02666-0.

Implementing HIV teams to improve HIV indicator condition-guided testing in general practitioner centers in the Netherlands

Carlijn C E Jordans  1 , Lotte Niemantsverdriet-Rokx  2 , Jan L Struik  2 , Eva C van der Waal  3 , Paul V J M van der Voorn  3 , Nienke Bakker  4 , Annelies Verbon  5 , Patrick J E Bindels  6 , Casper Rokx  7   8
Affiliations
Observational Study

Implementing HIV teams to improve HIV indicator condition-guided testing in general practitioner centers in the Netherlands

Carlijn C E Jordans et al. BMC Prim Care. .

Abstract

Background: HIV indicator condition-guided testing is recommended by guidelines to identify undiagnosed HIV infections. However, general practitioners (GPs) frequently see patients for indicator conditions without testing them for HIV. The aim of this study was to evaluate whether implementing HIV teams, using trained GP ambassadors, promoted local HIV indicator condition-guided testing practices in urban GP centers in the Netherlands.

Methods: We conducted a prospective implementation study between May 2021 and March 2023. Patients ≥ 18 years newly diagnosed with HIV indicator conditions in three GP centers were included. The intervention consisted of HIV expert led education for GPs with a stepwise implementation of point-of-care testing (phase 1), followed by adding peer-to-peer case feedback by trained GP ambassadors (phase 2). Questionnaires were used to assess the experiences and beliefs of HIV indicator condition-driven testing in patients and GPs. The primary outcome was the overall HIV testing rate in patients diagnosed with indicator conditions compared to pre-implementation. Secondary outcomes were HIV testing rate per phase and per indicator condition, HIV positivity rate, and patients' and GPs' experiences with this testing strategy.

Results: In 132,338 patient visits, 846 (0.6%, 95%CI 0.6-0.7%) HIV indicator conditions were diagnosed, including 485 sexually transmitted infections (57.3%). Overall, 215 (25.4%) indicator conditions were tested for HIV after the implementation of HIV teams. The testing rate was comparable between the two phases (25.2% versus 25.9%, p = 0.83). The testing rates pre- and post-implementation were comparable (21.3% versus 25.4%, p = 0.33). The most frequently tested HIV indicator conditions were unexplained weight loss (n = 13, 41.9%), unexplained lymphadenopathy (n = 8, 38.1%), and sexually transmitted infections (n = 161, 33.2%). Three patients (1.4%, 95%CI 0.3-4.0%) tested positive for HIV. Test acceptance in patients was high as was the self-perceived knowledge of GPs on HIV indicator conditions.

Conclusions: Implementing HIV teams did not enhance HIV indicator condition-guided testing in urban GP centers from a low HIV prevalence setting. The high patients acceptance rate and self-perceived knowledge among GPs regarding HIV indicator conditions did not manifest in high HIV testing rates. Patients accepted testing, but a gap was found between the self-perceived knowledge of GPs regarding HIV indicator conditions and testing, and the actual HIV testing rate.

Trial registration: ClinicalTrials.gov NCT05225493 (registration date: 17-01-2022).

Keywords: AIDS; Family care; General practitioner; HIV; HIV testing; Indicator condition; Primary care.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: The study procedures were carried out in accordance with the regulations of the Declaration of Helsinki. Approval of the research Medical Ethics Committee, Erasmus University Medical Center, Rotterdam, was obtained (MEC-2021-0277). The Medical Ethics Committee determined that this research did not meet the definition of medical research involving human subjects under Dutch law (WMO) and waived the need for individual informed consent with the use of data from routine care without processing of personal data. Separate informed consent was obtained from all participants who filled in the questionnaire before data collection. Consent for publication: Not applicable. Competing interests: CJ received travel funding from Gilead Sciences and received speaker funding from ViiV Healthcare, both outside the submitted work. CR received funding for investigator-initiated studies, and reimbursement for travel and participation in scientific advisory boards, from Gilead Sciences and ViiV Healthcare. Other authors reported no disclosures.

Figures

Fig. 1
Fig. 1
Flowchart of confirmed HIV indicator conditions, HIV testing rate, and reasons not to test for HIV. GP = general practitioner, HIV = human immunodeficiency virus
See this image and copyright information in PMC

References

    1. Europe ECfDPaCWrof. HIV/AIDS surveillance in Europe – 2022 data. 2023.
    1. Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428–38. - DOI - PMC - PubMed
    1. Guaraldi G, Zona S, Menozzi M, Brothers TD, Carli F, Stentarelli C, et al. Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study. AIDS Res Therapy. 2017;14(1):8. - DOI - PMC - PubMed
    1. Baggaley RF, Irvine MA, Leber W, Cambiano V, Figueroa J, McMullen H, et al. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis. Lancet HIV. 2017;4(10):e465–74. - DOI - PMC - PubMed
    1. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373(9):795–807. - DOI - PMC - PubMed

Publication types

Associated data

LinkOut - more resources